Abstract:Rationale: Immunocompromised patients who developed varicella-zoster virus (VZV)-associated disseminated intravascular coagulation (DIC) previously included recipients of bone marrow, hematopoietic stem cell, or organ transplantations, patients with primary nephropathy receiving corticosteroid therapy, cancer patients receiving chemotherapy, and patients with human immune deficiency virus infection. The case reported here is novel because, to our knowledge, there has been no report of VZV-associated DIC after the onset of Henoch-Schönlein purpura (HSP). Purpose: To report the successful treatment of a novel pediatric case with VZV-associated DIC secondary to HSP. Diagnosis and intervention: An 8-year-old girl developed VZV-associated DIC 24 days after diagnosis of HSP with renal and gastrointestinal involvement. She was treated with methylprednisolone at a local hospital for 19 days, and suddenly developed fever starting from day 4 in our hospital. Her fever persisted with vesicular skin rashes on her back, strong abdominal and lower back pain, epistaxis, hematochezia, erosion and bleeding on her lips, in her mouth and at puncture sites on day 5. She was diagnosed with DIC with the laboratory evidence of dramatically decreased platelet count and fibrinogen, prolonged activated partial thromboplastin time and prothrombin time, and increased fibrin degradation products including d-dimers. She also developed multiple organ dysfunction syndrome. On day 7, the patient VZV nucleic acid result turned out to be positive. Methylprednisolone treatment was discontinued, and she was given a multi-modality therapy including medications of acyclovir and antibiotics, intravenous gamma-immunoglobulin, various blood product transfusions, continuous renal replacement therapy, plasma exchange, and administration of liver and gastrointestinal system protection drugs. Outcomes: The patient multi-organ function damage gradually recovered. After VZV control, the patient was treated with oral methylprednisolone again for HSP with nephritis. Urine analysis was normal 1 year later, and oral hormone was discontinued. No complication or relapse occurred during 2 years of follow-up. Significance: This case report, for the first time, adds HSP treated with corticosteroids to the spectrum of clinical conditions that progressed to life-threatening secondary varicella-associated DIC. Early identification of varicella infection and DIC, combined with timely antiviral, immunoglobulin transfusion, plasma exchange, and other combined therapies are essential for saving patients' lives.

HENOCH-SCHÖNLEIN PURPURA NEPHRITIS FOLLOWING INFLUENZA VACCINATION: A CASE REPORT AND REVIEW OF THE LITERATURE

The Laboratory Differential Diagnosis of Henoch-Schonlein Purpura

Henoch-Schönlein purpura following COVID-19 vaccine in a child: a case report

Expansion of Circulating T Follicular Helper Cells in Children with Acute Henoch-Schönlein Purpura.

Presentations and outcome analysis of 205 adult patients with Henoch-Sch(o)nlein purpura nephritis

Henoch-Schönlein Purpura Following the First Dose of COVID-19 Viral Vector Vaccine: A Case Report

Henoch-Schonlein purpura in 535 chinese children: clinical features and risk factors for renal involvement

[Clinical characteristics of Henoch-Schönlein purpura in children]

Association of the infectious triggers with childhood Henoch-Schonlein purpura in Anhui province, China

Two cases of exudative retina detachment and uveitis following H1N1 influenza vaccination.

De Novo Immunoglobulin A Vasculitis Following Exposure to SARS-CoV-2 Immunization

Assessment of the herpes zoster risk among renal transplant recipients administered the influenza vaccine

Common Seasonal Pathogens and Epidemiology of Henoch-Schönlein Purpura Among Children

An adolescent girl diagnosed with IgA nephropathy following the first dose of the COVID-19 vaccine

Risk factors associated with recurrence of Henoch–Schonlein purpura: a retrospective study

Henoch-Schonlein Purpura Nephritis in Children: Incidence, Pathogenesis and Management

Immune function change and clinical significance in children patients with with Henoch-Schonlein purpura

The Research Progress of Pediatric Henoch-Schnlein Purpura

Relationship between immune parameters and organ involvement in children with Henoch-Schonlein purpura

Varicella-associated disseminated intravascular coagulation secondary to Henoch-Schönlein purpura with renal and gastrointestinal system involvement in a child: A case report

Henoch-Schönlein purpura with joint involvement: Analysis of 71 cases